Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...

Colorectal cancer is the second leading cause of cancer-related death globally. Although some of the molecular changes ...

Dubai, United Arab Emirates; May, 2025 - A discovery by Mayo Clinic researchers may help explain why immunotherapy hasn't ...

Experts explain the role that the bacteria plays in our gut, and how research suggests supplementing our bodies with it could ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is involved in lung repair and in ...

CytomX Therapeutics reveals promising CX-2501 results & strengthens finances with $100M offering. Key updates on cancer ...

HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing intravenously delivered cancer immunotherapies, announces it has raised USD ...

What is Akkermansia? Akkermansia muciniphila is a beneficial strain of probiotic bacteria that lives in the mucus that covers ...

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized with a blue ribbon “Poster of Distinction” ...

In a study published in the Journal of Clinical Investigation, researchers used mouse models and analyses of human colorectal ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...